Clinical Trial Update: Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire

View source ↗

Summary

This clinical trial update describes a study assessing minimal residual disease in ovarian cancer using circulating tumor DNA and immune repertoire analysis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Geneplus-Beijing Co. Ltd. | Conditions: Ovarian Cancer | Status: ACTIVE_NOT_RECRUITING